Search Results
#
Progress Update: Screening of FDA-approved compounds
Jun 10, 2021, 10:01 AM
Dr. Lek provides a final update to her screening grant.
#
Progress Update: Screening of FDA-approved compounds
Oct 6, 2020, 11:43 AM
Dr. Lek provides an update on progress establishing a pipeline for testing the therapeutic potential of the drugs to reduce DUX4 toxicity, starting with everolimus.
#
Progress Update: DUX4 activity in hESC-derived muscle
Nov 14, 2016, 10:40 AM
Final update for grant to Genea Biocells.
#
NCATS Tour
Jul 6, 2016, 6:05 PM
NCATS Leading Crucial, Collaborate Efforts to Advance Rare Diseases Research.
#
FSH Summit Report 2016
May 23, 2016, 4:44 PM
Report of FSHD Summit held in Portland, Oregon, February 29 to March 1 of 2016.
#
Research funding: a collaborative effort to silence DUX4
Jul 11, 2015, 12:02 PM
An industry/academic collaboration to test a lead compound in a potentially robust animal model of FSHD.
#
Research Funding: Genea Biocells to develop next generation screening platform for FSHD
May 4, 2015, 4:04 PM
Genea Biocells will develop a validated tool for the FSHD community - and we'll test important hypotheses along the way!